Secondary prevention with folic acid: results of the Goes extension study.
作者信息
Liem A, Reynierse-Buitenwerf G H, Zwinderman A H, Jukema J W, van Veldhuisen D J
出版信息
Heart. 2005 Sep;91(9):1213-4. doi: 10.1136/hrt.2004.035030.
Abstract
摘要
相似文献
1
Secondary prevention with folic acid: results of the Goes extension study.叶酸二级预防：Goes扩展研究结果
Heart. 2005 Sep;91(9):1213-4. doi: 10.1136/hrt.2004.035030.
2
3
Long-term follow-up of the West of Scotland Coronary Prevention Study.苏格兰西部冠心病预防研究的长期随访
N Engl J Med. 2008 Jan 10;358(2):194; author reply 194-5.
4
Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).克罗地亚缺血性冠状动脉事件的治疗与二级预防（TASPIC-CRO研究）
Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):646-54. doi: 10.1097/01.hjr.0000183910.59741.96.
5
How effective is prevention in coronary heart disease?冠心病的预防效果如何？
Heart. 2008 Nov;94(11):1370-1. doi: 10.1136/hrt.2007.133777.
6
[Reasons for the under-use of secondary prevention therapies in coronary patients over the age of 70 years].[70岁以上冠心病患者二级预防治疗使用不足的原因]
Ann Cardiol Angeiol (Paris). 2005 Dec;54 Suppl 1:S17-23.
7
Statins in the prevention of transplant coronary artery disease: in pediatric heart recipients.
Pediatr Transplant. 2007 Aug;11(5):459-60. doi: 10.1111/j.1399-3046.2007.00710.x.
8
Continuation of statin treatment and all-cause mortality: a population-based cohort study.他汀类药物治疗的持续时间与全因死亡率：一项基于人群的队列研究。
Arch Intern Med. 2009 Feb 9;169(3):260-8. doi: 10.1001/archinternmed.2008.552.
9
Long-term follow-up of the West of Scotland Coronary Prevention Study.苏格兰西部冠心病预防研究的长期随访
N Engl J Med. 2008 Jan 10;358(2):193-4; author reply 194-5.
10
Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.心肌梗死后联合二级预防治疗的影响：来自法国全国性登记处的数据。
Am Heart J. 2005 Dec;150(6):1147-53. doi: 10.1016/j.ahj.2005.01.058.
引用本文的文献
1
Effects of B Vitamins on Homocysteine Lowering and Thrombotic Risk Reduction-A Review of Randomized Controlled Trials Published Since January 1996.B族维生素对降低同型半胱氨酸水平及降低血栓形成风险的作用——1996年1月以来发表的随机对照试验综述
Nutrients. 2025 Mar 24;17(7):1122. doi: 10.3390/nu17071122.
2
The effect of folic acid in patients with cardiovascular disease: A systematic review and meta-analysis.叶酸对心血管疾病患者的影响：一项系统评价与荟萃分析。
Medicine (Baltimore). 2019 Sep;98(37):e17095. doi: 10.1097/MD.0000000000017095.
3
Folic Acid in Stroke Prevention in Countries without Mandatory Folic Acid Food Fortification: A Meta-Analysis of Randomized Controlled Trials.在无强制性叶酸食品强化的国家中，叶酸用于预防中风：一项随机对照试验的荟萃分析
J Stroke. 2018 Jan;20(1):99-109. doi: 10.5853/jos.2017.01522. Epub 2018 Jan 31.
4
Homocysteine-lowering interventions for preventing cardiovascular events.降低同型半胱氨酸水平预防心血管事件的干预措施。
Cochrane Database Syst Rev. 2017 Aug 17;8(8):CD006612. doi: 10.1002/14651858.CD006612.pub5.
5
B-vitamin Supplementation Mitigates Effects of Fine Particles on Cardiac Autonomic Dysfunction and Inflammation: A Pilot Human Intervention Trial.B 族维生素补充可减轻细颗粒物对心脏自主神经功能障碍和炎症的影响：一项初步人体干预试验。
Sci Rep. 2017 Apr 3;7:45322. doi: 10.1038/srep45322.
6
Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials.补充叶酸与心血管疾病风险：随机对照试验的荟萃分析
J Am Heart Assoc. 2016 Aug 15;5(8):e003768. doi: 10.1161/JAHA.116.003768.
7
The effect of folate fortification on folic acid-based homocysteine-lowering intervention and stroke risk: a meta-analysis.叶酸强化对基于叶酸的降低同型半胱氨酸干预及中风风险的影响：一项荟萃分析。
Public Health Nutr. 2015 Jun;18(8):1514-21. doi: 10.1017/S1368980014002134. Epub 2014 Oct 17.
8
Association between B vitamins supplementation and risk of cardiovascular outcomes: a cumulative meta-analysis of randomized controlled trials.补充B族维生素与心血管疾病结局风险之间的关联：随机对照试验的累积荟萃分析
PLoS One. 2014 Sep 19;9(9):e107060. doi: 10.1371/journal.pone.0107060. eCollection 2014.
9
The association between B vitamins supplementation and adverse cardiovascular events: a meta-analysis.补充B族维生素与不良心血管事件之间的关联：一项荟萃分析。
Int J Clin Exp Med. 2014 Aug 15;7(8):1923-30. eCollection 2014.
10
Effect of B-vitamin supplementation on stroke: a meta-analysis of randomized controlled trials.B 族维生素补充对卒中的影响：一项随机对照试验的荟萃分析。
PLoS One. 2013 Nov 25;8(11):e81577. doi: 10.1371/journal.pone.0081577. eCollection 2013.
本文引用的文献
1
Folate therapy and in-stent restenosis after coronary stenting.叶酸治疗与冠状动脉支架置入术后支架内再狭窄
N Engl J Med. 2004 Jun 24;350(26):2673-81. doi: 10.1056/NEJMoa032845.
2
Sources of diagnostic inaccuracy of conventional versus new diagnostic criteria for myocardial infarction in an unselected UK population with suspected cardiac chest pain, and investigation of independent prognostic variables.在英国未经过选择的疑似心脏性胸痛人群中，心肌梗死传统诊断标准与新诊断标准诊断不准确的来源，以及独立预后变量的研究。
Heart. 2003 Dec;89(12):1406-10. doi: 10.1136/heart.89.12.1406.
3
Secondary prevention with folic acid: effects on clinical outcomes.叶酸二级预防：对临床结局的影响。
J Am Coll Cardiol. 2003 Jun 18;41(12):2105-13. doi: 10.1016/s0735-1097(03)00485-6.
4
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis.同型半胱氨酸与心血管疾病：一项荟萃分析得出的因果关系证据
BMJ. 2002 Nov 23;325(7374):1202. doi: 10.1136/bmj.325.7374.1202.
5
Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.同型半胱氨酸与缺血性心脏病和中风风险：一项荟萃分析。
JAMA. 2002;288(16):2015-22. doi: 10.1001/jama.288.16.2015.
Zotero 插件